Loading…
NDM Production as a Dominant Feature in Carbapenem-Resistant Enterobacteriaceae Isolates from a Tertiary Care Hospital
The worldwide spread and increasing prevalence of carbapenem-resistant Enterobacteriaceae (CRE) is of utmost concern and a problem for public health. This resistance is mainly conferred by carbapenemase production. Such strains are a potential source of outbreaks in healthcare settings and are assoc...
Saved in:
Published in: | Antibiotics (Basel) 2021-12, Vol.11 (1), p.48 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c499t-f8e40d0cccbc98c57fe33828ea0d89d511395fc95f142128ce92e7a5155e8a683 |
---|---|
cites | cdi_FETCH-LOGICAL-c499t-f8e40d0cccbc98c57fe33828ea0d89d511395fc95f142128ce92e7a5155e8a683 |
container_end_page | |
container_issue | 1 |
container_start_page | 48 |
container_title | Antibiotics (Basel) |
container_volume | 11 |
creator | Uddin, Fakhur Imam, Syed Hadi Khan, Saeed Khan, Taseer Ahmed Ahmed, Zulfiqar Sohail, Muhammad Elnaggar, Ashraf Y Fallatah, Ahmed M El-Bahy, Zeinhom M |
description | The worldwide spread and increasing prevalence of carbapenem-resistant Enterobacteriaceae (CRE) is of utmost concern and a problem for public health. This resistance is mainly conferred by carbapenemase production. Such strains are a potential source of outbreaks in healthcare settings and are associated with high rates of morbidity and mortality. In this study, we aimed to determine the dominance of NDM-producing Enterobacteriaceae at a teaching hospital in Karachi. A total of 238 Enterobacteriaceae isolates were collected from patients admitted to Jinnah Postgraduate Medical Centre (Unit 4) in Karachi, Pakistan, a tertiary care hospital. Phenotypic and genotypic methods were used for detection of metallo-β-lactamase. Out of 238 isolates, 52 (21.8%) were CRE and 50 isolates were carbapenemase producers, as determined by the CARBA NP test; two isolates were found negative for carbapenemase production by CARB NP and PCR. Four carbapenemase-producing isolates phenotypically appeared negative for metallo-β-lactamase (MBL). Of the 52 CRE isolates, 46 (88.46%) were
positive. Most of the NDM producers were
, followed by
and
. In all the NDM-positive isolates, the
gene was found on plasmid. These isolates were found negative for the VIM and IPM MBLs. All the CRE and carbapenem-sensitive isolates were sensitive to colistin. It is concluded that the NDM is the main resistance mechanism against carbapenems and is dominant in this region. |
doi_str_mv | 10.3390/antibiotics11010048 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_7821a4523aba4bd59437d3817fb7ccab</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_7821a4523aba4bd59437d3817fb7ccab</doaj_id><sourcerecordid>2622284857</sourcerecordid><originalsourceid>FETCH-LOGICAL-c499t-f8e40d0cccbc98c57fe33828ea0d89d511395fc95f142128ce92e7a5155e8a683</originalsourceid><addsrcrecordid>eNptkl1rFTEQhhdRbKn9BYIEvPFmNR-bk-RGkNPWHqgfSL0Os9nZmsNuckyyBf-9OZ5aWjEQJmTeefJOmKZ5yehbIQx9B6H43sfiXWaMMko7_aQ55lSZdiU0f_rgfNSc5ryldRkmNNXPmyMhqeSGy-Pm9vPZJ_I1xWFxxcdAIBMgZ3H2ob5ALhDKkpD4QNaQethhwLn9htnnss-fh4Ip9uBq8OAQkGxynKBgJmOKc2VdYyoe0q89AMllzDtfYHrRPBthynh6F0-a7xfn1-vL9urLx836w1XrOmNKO2rs6ECdc70z2kk1oqgdaQQ6aDNIxoSRo6ubdZxx7dBwVCCZlKhhpcVJszlwhwhbu0t-rlZsBG__XMR0Y6H6cxNapTmDTnIBPXT9IE0n1CA0U2OvnIO-st4fWLuln3FwGEqC6RH0cSb4H_Ym3lqtFNeCVcCbO0CKPxfMxc4-O5wmCBiXbPmKc647LVWVvv5Huo1LCvWr9irGO0PFqqrEQeVSzDnheG-GUbsfE_ufMalVrx72cV_zdyjEb_tYvP8</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2621249036</pqid></control><display><type>article</type><title>NDM Production as a Dominant Feature in Carbapenem-Resistant Enterobacteriaceae Isolates from a Tertiary Care Hospital</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Uddin, Fakhur ; Imam, Syed Hadi ; Khan, Saeed ; Khan, Taseer Ahmed ; Ahmed, Zulfiqar ; Sohail, Muhammad ; Elnaggar, Ashraf Y ; Fallatah, Ahmed M ; El-Bahy, Zeinhom M</creator><creatorcontrib>Uddin, Fakhur ; Imam, Syed Hadi ; Khan, Saeed ; Khan, Taseer Ahmed ; Ahmed, Zulfiqar ; Sohail, Muhammad ; Elnaggar, Ashraf Y ; Fallatah, Ahmed M ; El-Bahy, Zeinhom M</creatorcontrib><description>The worldwide spread and increasing prevalence of carbapenem-resistant Enterobacteriaceae (CRE) is of utmost concern and a problem for public health. This resistance is mainly conferred by carbapenemase production. Such strains are a potential source of outbreaks in healthcare settings and are associated with high rates of morbidity and mortality. In this study, we aimed to determine the dominance of NDM-producing Enterobacteriaceae at a teaching hospital in Karachi. A total of 238 Enterobacteriaceae isolates were collected from patients admitted to Jinnah Postgraduate Medical Centre (Unit 4) in Karachi, Pakistan, a tertiary care hospital. Phenotypic and genotypic methods were used for detection of metallo-β-lactamase. Out of 238 isolates, 52 (21.8%) were CRE and 50 isolates were carbapenemase producers, as determined by the CARBA NP test; two isolates were found negative for carbapenemase production by CARB NP and PCR. Four carbapenemase-producing isolates phenotypically appeared negative for metallo-β-lactamase (MBL). Of the 52 CRE isolates, 46 (88.46%) were
positive. Most of the NDM producers were
, followed by
and
. In all the NDM-positive isolates, the
gene was found on plasmid. These isolates were found negative for the VIM and IPM MBLs. All the CRE and carbapenem-sensitive isolates were sensitive to colistin. It is concluded that the NDM is the main resistance mechanism against carbapenems and is dominant in this region.</description><identifier>ISSN: 2079-6382</identifier><identifier>EISSN: 2079-6382</identifier><identifier>DOI: 10.3390/antibiotics11010048</identifier><identifier>PMID: 35052925</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Antimicrobial agents ; carbapenem-resistant Enterobacteriaceae ; Carbapenemase ; Carbapenems ; Colistin ; CRE bacteria ; Drug resistance ; E coli ; Enterobacter cloacae ; Enterobacteriaceae ; Health care ; Health care facilities ; Infections ; Klebsiella ; Metallo-β-lactamase ; metallo-β-lactamases ; Metallography ; Morbidity ; NDM producers ; Pathogens ; Plasmids ; Public health ; Surveillance ; β Lactamase</subject><ispartof>Antibiotics (Basel), 2021-12, Vol.11 (1), p.48</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c499t-f8e40d0cccbc98c57fe33828ea0d89d511395fc95f142128ce92e7a5155e8a683</citedby><cites>FETCH-LOGICAL-c499t-f8e40d0cccbc98c57fe33828ea0d89d511395fc95f142128ce92e7a5155e8a683</cites><orcidid>0000-0002-7208-9441 ; 0000-0001-7168-7709</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2621249036/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2621249036?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35052925$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uddin, Fakhur</creatorcontrib><creatorcontrib>Imam, Syed Hadi</creatorcontrib><creatorcontrib>Khan, Saeed</creatorcontrib><creatorcontrib>Khan, Taseer Ahmed</creatorcontrib><creatorcontrib>Ahmed, Zulfiqar</creatorcontrib><creatorcontrib>Sohail, Muhammad</creatorcontrib><creatorcontrib>Elnaggar, Ashraf Y</creatorcontrib><creatorcontrib>Fallatah, Ahmed M</creatorcontrib><creatorcontrib>El-Bahy, Zeinhom M</creatorcontrib><title>NDM Production as a Dominant Feature in Carbapenem-Resistant Enterobacteriaceae Isolates from a Tertiary Care Hospital</title><title>Antibiotics (Basel)</title><addtitle>Antibiotics (Basel)</addtitle><description>The worldwide spread and increasing prevalence of carbapenem-resistant Enterobacteriaceae (CRE) is of utmost concern and a problem for public health. This resistance is mainly conferred by carbapenemase production. Such strains are a potential source of outbreaks in healthcare settings and are associated with high rates of morbidity and mortality. In this study, we aimed to determine the dominance of NDM-producing Enterobacteriaceae at a teaching hospital in Karachi. A total of 238 Enterobacteriaceae isolates were collected from patients admitted to Jinnah Postgraduate Medical Centre (Unit 4) in Karachi, Pakistan, a tertiary care hospital. Phenotypic and genotypic methods were used for detection of metallo-β-lactamase. Out of 238 isolates, 52 (21.8%) were CRE and 50 isolates were carbapenemase producers, as determined by the CARBA NP test; two isolates were found negative for carbapenemase production by CARB NP and PCR. Four carbapenemase-producing isolates phenotypically appeared negative for metallo-β-lactamase (MBL). Of the 52 CRE isolates, 46 (88.46%) were
positive. Most of the NDM producers were
, followed by
and
. In all the NDM-positive isolates, the
gene was found on plasmid. These isolates were found negative for the VIM and IPM MBLs. All the CRE and carbapenem-sensitive isolates were sensitive to colistin. It is concluded that the NDM is the main resistance mechanism against carbapenems and is dominant in this region.</description><subject>Antimicrobial agents</subject><subject>carbapenem-resistant Enterobacteriaceae</subject><subject>Carbapenemase</subject><subject>Carbapenems</subject><subject>Colistin</subject><subject>CRE bacteria</subject><subject>Drug resistance</subject><subject>E coli</subject><subject>Enterobacter cloacae</subject><subject>Enterobacteriaceae</subject><subject>Health care</subject><subject>Health care facilities</subject><subject>Infections</subject><subject>Klebsiella</subject><subject>Metallo-β-lactamase</subject><subject>metallo-β-lactamases</subject><subject>Metallography</subject><subject>Morbidity</subject><subject>NDM producers</subject><subject>Pathogens</subject><subject>Plasmids</subject><subject>Public health</subject><subject>Surveillance</subject><subject>β Lactamase</subject><issn>2079-6382</issn><issn>2079-6382</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkl1rFTEQhhdRbKn9BYIEvPFmNR-bk-RGkNPWHqgfSL0Os9nZmsNuckyyBf-9OZ5aWjEQJmTeefJOmKZ5yehbIQx9B6H43sfiXWaMMko7_aQ55lSZdiU0f_rgfNSc5ryldRkmNNXPmyMhqeSGy-Pm9vPZJ_I1xWFxxcdAIBMgZ3H2ob5ALhDKkpD4QNaQethhwLn9htnnss-fh4Ip9uBq8OAQkGxynKBgJmOKc2VdYyoe0q89AMllzDtfYHrRPBthynh6F0-a7xfn1-vL9urLx836w1XrOmNKO2rs6ECdc70z2kk1oqgdaQQ6aDNIxoSRo6ubdZxx7dBwVCCZlKhhpcVJszlwhwhbu0t-rlZsBG__XMR0Y6H6cxNapTmDTnIBPXT9IE0n1CA0U2OvnIO-st4fWLuln3FwGEqC6RH0cSb4H_Ym3lqtFNeCVcCbO0CKPxfMxc4-O5wmCBiXbPmKc647LVWVvv5Huo1LCvWr9irGO0PFqqrEQeVSzDnheG-GUbsfE_ufMalVrx72cV_zdyjEb_tYvP8</recordid><startdate>20211231</startdate><enddate>20211231</enddate><creator>Uddin, Fakhur</creator><creator>Imam, Syed Hadi</creator><creator>Khan, Saeed</creator><creator>Khan, Taseer Ahmed</creator><creator>Ahmed, Zulfiqar</creator><creator>Sohail, Muhammad</creator><creator>Elnaggar, Ashraf Y</creator><creator>Fallatah, Ahmed M</creator><creator>El-Bahy, Zeinhom M</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-7208-9441</orcidid><orcidid>https://orcid.org/0000-0001-7168-7709</orcidid></search><sort><creationdate>20211231</creationdate><title>NDM Production as a Dominant Feature in Carbapenem-Resistant Enterobacteriaceae Isolates from a Tertiary Care Hospital</title><author>Uddin, Fakhur ; Imam, Syed Hadi ; Khan, Saeed ; Khan, Taseer Ahmed ; Ahmed, Zulfiqar ; Sohail, Muhammad ; Elnaggar, Ashraf Y ; Fallatah, Ahmed M ; El-Bahy, Zeinhom M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c499t-f8e40d0cccbc98c57fe33828ea0d89d511395fc95f142128ce92e7a5155e8a683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antimicrobial agents</topic><topic>carbapenem-resistant Enterobacteriaceae</topic><topic>Carbapenemase</topic><topic>Carbapenems</topic><topic>Colistin</topic><topic>CRE bacteria</topic><topic>Drug resistance</topic><topic>E coli</topic><topic>Enterobacter cloacae</topic><topic>Enterobacteriaceae</topic><topic>Health care</topic><topic>Health care facilities</topic><topic>Infections</topic><topic>Klebsiella</topic><topic>Metallo-β-lactamase</topic><topic>metallo-β-lactamases</topic><topic>Metallography</topic><topic>Morbidity</topic><topic>NDM producers</topic><topic>Pathogens</topic><topic>Plasmids</topic><topic>Public health</topic><topic>Surveillance</topic><topic>β Lactamase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uddin, Fakhur</creatorcontrib><creatorcontrib>Imam, Syed Hadi</creatorcontrib><creatorcontrib>Khan, Saeed</creatorcontrib><creatorcontrib>Khan, Taseer Ahmed</creatorcontrib><creatorcontrib>Ahmed, Zulfiqar</creatorcontrib><creatorcontrib>Sohail, Muhammad</creatorcontrib><creatorcontrib>Elnaggar, Ashraf Y</creatorcontrib><creatorcontrib>Fallatah, Ahmed M</creatorcontrib><creatorcontrib>El-Bahy, Zeinhom M</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Antibiotics (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uddin, Fakhur</au><au>Imam, Syed Hadi</au><au>Khan, Saeed</au><au>Khan, Taseer Ahmed</au><au>Ahmed, Zulfiqar</au><au>Sohail, Muhammad</au><au>Elnaggar, Ashraf Y</au><au>Fallatah, Ahmed M</au><au>El-Bahy, Zeinhom M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NDM Production as a Dominant Feature in Carbapenem-Resistant Enterobacteriaceae Isolates from a Tertiary Care Hospital</atitle><jtitle>Antibiotics (Basel)</jtitle><addtitle>Antibiotics (Basel)</addtitle><date>2021-12-31</date><risdate>2021</risdate><volume>11</volume><issue>1</issue><spage>48</spage><pages>48-</pages><issn>2079-6382</issn><eissn>2079-6382</eissn><abstract>The worldwide spread and increasing prevalence of carbapenem-resistant Enterobacteriaceae (CRE) is of utmost concern and a problem for public health. This resistance is mainly conferred by carbapenemase production. Such strains are a potential source of outbreaks in healthcare settings and are associated with high rates of morbidity and mortality. In this study, we aimed to determine the dominance of NDM-producing Enterobacteriaceae at a teaching hospital in Karachi. A total of 238 Enterobacteriaceae isolates were collected from patients admitted to Jinnah Postgraduate Medical Centre (Unit 4) in Karachi, Pakistan, a tertiary care hospital. Phenotypic and genotypic methods were used for detection of metallo-β-lactamase. Out of 238 isolates, 52 (21.8%) were CRE and 50 isolates were carbapenemase producers, as determined by the CARBA NP test; two isolates were found negative for carbapenemase production by CARB NP and PCR. Four carbapenemase-producing isolates phenotypically appeared negative for metallo-β-lactamase (MBL). Of the 52 CRE isolates, 46 (88.46%) were
positive. Most of the NDM producers were
, followed by
and
. In all the NDM-positive isolates, the
gene was found on plasmid. These isolates were found negative for the VIM and IPM MBLs. All the CRE and carbapenem-sensitive isolates were sensitive to colistin. It is concluded that the NDM is the main resistance mechanism against carbapenems and is dominant in this region.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35052925</pmid><doi>10.3390/antibiotics11010048</doi><orcidid>https://orcid.org/0000-0002-7208-9441</orcidid><orcidid>https://orcid.org/0000-0001-7168-7709</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2079-6382 |
ispartof | Antibiotics (Basel), 2021-12, Vol.11 (1), p.48 |
issn | 2079-6382 2079-6382 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_7821a4523aba4bd59437d3817fb7ccab |
source | Publicly Available Content Database; PubMed Central |
subjects | Antimicrobial agents carbapenem-resistant Enterobacteriaceae Carbapenemase Carbapenems Colistin CRE bacteria Drug resistance E coli Enterobacter cloacae Enterobacteriaceae Health care Health care facilities Infections Klebsiella Metallo-β-lactamase metallo-β-lactamases Metallography Morbidity NDM producers Pathogens Plasmids Public health Surveillance β Lactamase |
title | NDM Production as a Dominant Feature in Carbapenem-Resistant Enterobacteriaceae Isolates from a Tertiary Care Hospital |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T23%3A56%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NDM%20Production%20as%20a%20Dominant%20Feature%20in%20Carbapenem-Resistant%20Enterobacteriaceae%20Isolates%20from%20a%20Tertiary%20Care%20Hospital&rft.jtitle=Antibiotics%20(Basel)&rft.au=Uddin,%20Fakhur&rft.date=2021-12-31&rft.volume=11&rft.issue=1&rft.spage=48&rft.pages=48-&rft.issn=2079-6382&rft.eissn=2079-6382&rft_id=info:doi/10.3390/antibiotics11010048&rft_dat=%3Cproquest_doaj_%3E2622284857%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c499t-f8e40d0cccbc98c57fe33828ea0d89d511395fc95f142128ce92e7a5155e8a683%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2621249036&rft_id=info:pmid/35052925&rfr_iscdi=true |